コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 and ATP but not by diphosphate nucleotides (P2Y2 receptor).
2 released ATP, which activates the purinergic P2Y2 receptor.
3 ctivated Cl- conductance is regulated by the P2Y2 receptor.
4 that is pharmacologically distinct from the P2Y2 receptor.
5 tent with alpha5beta1 transactivation by the P2Y2 receptor.
6 play a major role in apical targeting of the P2Y2 receptor.
7 ere similar for the wild-type and all mutant P2Y2 receptors.
8 r Ca(2+) release and vascular remodeling via P2Y2 receptors.
9 uding UTP, decrease ENaC activity via apical P2Y2 receptors.
10 shape, confirming the presence of functional P2Y2 receptors.
11 inding to purinergic receptors including the P2Y(2) receptor.
12 ective antagonist, suggesting a role for the P2Y(2) receptor.
13 hasizing the essential roles for ATP and the P2Y(2) receptor.
14 ted inositol phosphate response of the M1 or P2Y(2) receptor.
15 expression, indicating a mitogenic role for P2Y(2) receptors.
17 enetic or small interfering RNA depletion of P2Y(2) receptors abolished the ATPgammaS-mediated increa
19 investigated the role of allergen-stimulated P2Y(2) receptor activation in regulating adenosine triph
20 ade of the PLC/Ca(2+) pathway did not affect P2Y(2) receptor activation of p38, JNK, and TF induction
22 irway epithelial surface reach the range for P2Y2 receptor activation by physiological stimuli and id
23 criptase polymerase chain reaction) and that P2Y2 receptor activation is the principal means by which
27 s show that uridine 5'-triphosphate (UTP), a P2Y(2) receptor agonist, is effective at acutely enhanci
28 n in A431 cell number (p<0.001), whereas the P2Y2 receptor agonist uridine 5'-triphosphate caused a s
29 the nonspecific P2 receptor agonist ATP, the P2Y2 receptor agonist UTP (p<0.001), and the P2Y1 recept
30 on of P2Y2-HA receptor-expressing cells with P2Y2 receptor agonists also resulted in receptor-specifi
31 ay goblet cells secrete mucin in response to P2Y2 receptor agonists and to secretagogues, phorbol 12-
34 its the EGFR into a protein complex with the P2Y(2) receptor and allows Src to efficiently phosphoryl
36 f PGE(2) required activation of metabotropic P2Y(2) receptors and CRAC channel-mediated cytosolic pho
37 ssociation of tyrosine receptor kinase A and P2Y(2) receptors and is required for enhanced neuronal d
38 tinct temporal profiles of PLC activation by P2Y(2) receptors and mAChR may arise from the differenti
40 tor subtypes, the Gq-coupled ATP/UTP-sensing P2Y2 receptor and the Gs-coupled A2b adenosine receptor.
41 sistent with the established affinity of the P2Y2 receptor and the known kinetics of autophagy induct
43 was equipotent to UTP as an agonist at human P2Y2 receptors and also activated P2Y4 receptors with an
44 teracting systems--extracellular nucleotides/P2Y2 receptors and neurotrophin/TrkA--to sustain neurona
46 protein kinase responses through endogenous P2Y2 receptors, and these responses were not blocked by
47 2, and P2Y13 receptors; the ATP/UTP-specific P2Y2 receptor; and the ATP-selective P2Y11 receptor.
50 cade immediately upstream of MAP kinase, the P2Y2 receptor appears to uniquely utilize [Ca2+]i, PKC,
52 2X7 or P2Y2 receptor knock-out mice indicate P2Y2 receptors are involved in the activation of STAT3 a
53 , UTP, and ATPgammaS, an effect mediated via P2Y2 receptors, as demonstrated by small interfering RNA
55 lease and autocrine purinergic signaling via P2Y2 receptors at the front and A2a receptors at the bac
56 , which indicates upregulation of functional P2Y2 receptors at which UTP and ATP are equipotent agoni
58 nhibited by suramin or by siRNA silencing of P2Y(2) receptor, but not by NF-157, a P2Y(11)-selective
59 only by basolateral nucleotides, mediated by P2Y(2) receptors, but also by luminal nucleotides, media
61 ted that the activation of G-protein-coupled P2Y2 receptors by extracellular ATP and UTP stimulated M
62 addressed the hypothesis that activation of P2Y2 receptors by extracellular nucleotides modulates th
64 PANX1) channels and autocrine stimulation of P2Y2 receptors contribute to the excitatory signals at t
65 l roles in the human epidermis with P2Y1 and P2Y2 receptors controlling proliferation, while P2X5 and
66 f hBE cells to Alternaria extract stimulated P2Y(2) receptors coupled to phospholipase C beta(3), lea
67 , whereas inhibition by UTP, which activates P2Y2 receptors coupled to Gq/11 and Gi3, was not affecte
69 edullary thick ascending limbs isolated from P2Y2 receptor-deficient mice compared with wild type.
73 xycorticosterone acetate and deletion of the P2Y(2) receptor each modestly increased the resistance o
75 knockout mice, we propose that a blunting in P2Y2 receptor expression or activity is a new mechanism
76 nding of Src to the SH3 binding sites in the P2Y(2) receptor facilitates Src activation, which recrui
78 kinase C activation, which desensitizes the P2Y2 receptor, had no effect on sequestration, consisten
79 cell types, purinergic signaling through the P2Y2 receptor has the potential to downregulate the sens
80 uent activation of Gq/G11-coupled purinergic P2Y2 receptors have been shown to mediate fluid shear st
81 that gene-targeted (knockout) mice that lack P2Y2 receptors have salt-resistant arterial hypertension
82 Furthermore, Src co-precipitated with the P2Y(2) receptor in 1321N1 astrocytoma cells stimulated w
87 Apical release of ATP and UTP can activate P2Y(2) receptors in the aldosterone-sensitive distal nep
90 of mRNA expression for the G protein-coupled P2Y2 receptor in mouse thymocytes after the addition of
91 pes indicates the predominant involvement of P2Y2 receptor in P2X3 inhibition, and immunolocalization
92 These findings suggest a novel role for the P2Y2 receptor in the p38- and Rho kinase-dependent expre
93 tracellular nucleotide signaling through the P2Y2 receptor in the survival of neurons: PC12 (pheochro
94 identify a previously unrecognized role for P2Y2 receptors in blood pressure regulation that is link
97 ular injury, suggesting a potential role for P2Y2 receptors in monocyte recruitment by vascular endot
98 hat mitochondria deliver ATP that stimulates P2Y2 receptors in response to chemotactic cues, and that
101 logy model of the nucleotide-activated human P2Y2 receptor, including loops, termini, and phospholipi
103 ype is not yet known, but stimulation of the P2Y2 receptor increases IL-1-mediated PGE2 release.
104 s study investigates whether deletion of the P2Y(2) receptor influences the development of arterial m
110 ATP release from renal epithelia, which via P2Y2 receptors is the main mediator of HlyA-induced [Ca(
111 ion that the G protein-coupled P2U receptor (P2Y2 receptor) is activated by UTP as well as ATP provid
112 oupled P2Y receptor that, like the mammalian P2Y2 receptor, is activated by both adenine and uridine
115 by 5-8 fold, an effect largely eliminated by P2Y(2) receptor knockdown or ATP hydrolysis with apyrase
123 lymerase chain reaction analysis showed that P2Y(2) receptor mRNA was dramatically increased in cells
126 It is proposed that the rapid increase of P2Y2 receptor mRNA expression could be a common early ev
128 mocytes, the observed rapid up-regulation of P2Y2 receptor mRNA expression may reflect an immediate e
129 e possibility that the observed increases in P2Y2 receptor mRNA expression were due to the enrichment
130 ollar placement caused rapid upregulation of P2Y2 receptor mRNA in medial SMCs before appearance of n
132 Although UDP does not activate the human P2Y2 receptor, mucosal addition of UDP promoted [3H]inos
135 tory response to CO(2), and re-expression of P2Y(2) receptors only in RTN smooth muscle cells fully r
138 epithelia, we tested the hypothesis that the P2Y(2) receptor (P2Y(2)-R) subtype mediates these respon
139 ssect the functions of extracellular ATP and P2Y(2) receptors (P2Y(2)R) during hepatocarcinogenesis.
143 ted that activation of the G protein-coupled P2Y2 receptor (P2Y2R) subtype expressed in human 1321N1
144 xtracellular ATP signaled through purinergic P2Y2 receptor (P2Y2R) to activate protein kinase Ca (PKC
145 currents was mediated by a G-protein-coupled P2Y(2) receptor/PKC pathway, whereas the effect of UTP o
146 m the C-terminal domains of human P2Y(1) and P2Y(2) receptors produced a shift in the voltage depende
147 rs in response to chemotactic cues, and that P2Y2 receptors promote mTOR signaling, which augments mi
148 s a reporter system for detection of ATP via P2Y2 receptor-promoted formation of [3H]inositol phospha
150 (most likely, endothelial ATP/UTP-selective P2Y(2)) receptors, rather than via its dephosphorylation
153 identify the apical targeting signal in the P2Y2 receptor, regions of the P2Y2 receptor were progres
155 domains of either the human P2Y(1) or human P2Y(2) receptor resulted in voltage dependence and inact
159 urkey erythrocyte P2Y(1) or human P2Y(1) and P2Y(2) receptors stably expressed in astrocytoma cells.
160 lls, an airway goblet cell model, purinergic P2Y(2) receptor-stimulated increase of cytosolic Ca(2+)
162 helial cells was found to involve purinergic P2Y(2) receptor stimulation, and both ligand-dependent m
163 ated the expression of P2X5, P2X7, P2Y1, and P2Y2 receptor subtypes in 8- to 11-wk-old human fetal ep
164 gated the expression of P2X5, P2X7, P2Y1 and P2Y2 receptor subtypes in normal human epidermis and in
165 es indicate a key role of the apical ATP/UTP-P2Y(2)-receptor system in the inhibition of ENaC P(o) in
166 Mutation of RGD to RGE had no effect on P2Y2 receptor targeting, indicating that receptor-integr
167 tion to confirming the presence of classical P2Y2 receptors, these results also provide functional ev
170 We linked the activation of this engineered P2Y2 receptor to the secretion of the ATP-degrading enzy
175 ibition by ATP, which activates both P2X and P2Y2 receptors, was not affected by zero Ca2+ alone; but
176 signal in the P2Y2 receptor, regions of the P2Y2 receptor were progressively substituted with the co
177 th, 1321N1 cells stably expressing the human P2Y2 receptor were used as a reporter system for detecti
180 ell transfectants expressing the recombinant P2Y2 receptor, whereas vector-transfected control cells
181 In conclusion, we have cloned the porcine P2Y(2) receptor with novel pharmacology and demonstrated